17-50187014-C-T
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000088.4(COL1A1):c.3531+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000088.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- Caffey diseaseInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen
- combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, arthrochalasia typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen
- osteogenesis imperfecta type 1Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- osteogenesis imperfecta type 2Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- osteogenesis imperfecta type 3Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- osteogenesis imperfecta type 4Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen
- Ehlers-Danlos syndrome, classic type, 1Inheritance: AD Classification: MODERATE Submitted by: ClinGen
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ehlers-Danlos/osteogenesis imperfecta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- high bone mass osteogenesis imperfectaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000088.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COL1A1 | NM_000088.4 | MANE Select | c.3531+1G>A | splice_donor intron | N/A | NP_000079.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COL1A1 | ENST00000225964.10 | TSL:1 MANE Select | c.3531+1G>A | splice_donor intron | N/A | ENSP00000225964.6 | |||
| COL1A1 | ENST00000510710.3 | TSL:2 | n.109G>A | non_coding_transcript_exon | Exon 1 of 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Osteogenesis imperfecta Pathogenic:2
The COL1A1 c.3531+1G>A variant occurs in a canonical splice site (donor) and is predicted to disrupt the normal gene product. The c.3531+1G>A variant has been reported in a heterozygous state in an individual with osteogenesis imperfecta, type I (Willing et al. 1994). The c.3531+1G>A variant is not found in version 2.1.1 or version 3.1.2 of the Genome Aggregation Database despite its location in a region of good sequencing coverage, which suggests the variant is rare. Experimental studies have shown that the variant leads to preservation of the reading frame with skipping of exon 48 and reduced mRNA levels (Willing et al. 1994). Other nucleotides changes at this same position have been reported in at least three individuals with osteogenesis imperfecta (Bardai et al. 2016; Essawi et al. 2018). Based on the collective evidence, the c.3531+1G>A variant is classified as pathogenic for COL1A1-related osteogenesis imperfecta.
Osteogenesis imperfecta type I Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in COL1A1 are known to be pathogenic (PMID: 7942841, 9295084, 9443882). Experimental studies have shown that this splice variant leads to skipping of exon 48 and reduced mRNA levels (PMID: 7942841). This variant has been reported in an individual affected with osteogenesis imperfecta type I (PMID: 7942841). The variant is also known as a substitution at the 5' donor splice site at position +1 of intron 48. This variant is not present in population databases (ExAC no frequency). This sequence change affects a donor splice site in intron 47 of the COL1A1 gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at